Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study

Study limitation reported by the research below: “Claims-based outcome ascertainment cannot fully capture disease activity flares, which may confound immunosuppressant switching and infection risk.”